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Abstract
Two different isoforms of the adenine nucleotide translocase (ANT1 and ANT2) have been identified in the rat. In order to
obtain enhanced knowledge of the ANT isoform expression, we analyzed the transcription pattern of both isoforms and their
mRNA levels in various tissues of the rat using the PCR technique. A predominant ANT1 mRNA percentage was recorded
in the skeletal muscle, heart and brain, ranging from 81 to 58%. In contrast to these tissues, the percentages of ANT2 were
dominant with a range from 59 to 75% in the kidney, lung, spleen and liver. The level of total ANT mRNA varied markedly
in the various organs. Tissues with a dominant ANT1 percentage simultaneously showed a high level of total ANT
transcription (24^41 attomol/ng total RNA). In comparison to the latter, tissues with a prevalent ANT2 transcription were
shown to have an even lower ANT transcription level (2^5 attomol/ng total RNA). The predominance of the ANT1
expression appeared to be restricted to tissues with an inability to regenerate by means of mitotic division, whereas a
prevalent ANT2 transcription is found in cell types able to proliferate. The level of total ANT transcription but not the
individual ANT isoform expression depends to a great extent on the energy requirements of the tissue. ß 1999 Elsevier
Science B.V. All rights reserved.
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1. Introduction
The adenine nucleotide translocase (ANT) is an
integral protein of the inner mitochondrial mem-
brane [1,2]. It enables the transport of ADP and
ATP across the impermeable mitochondrial mem-
brane. Consequently, the ANT links the energy con-
suming reactions in the cytosol to the energy produc-
ing processes in the mitochondrion. The ANT
consists of two identical subunits of 32 kDa with a
single binding site for ATP and ADP, which alter-
nately faces the matrix (m conformation) or the cy-
tosolic side of the membrane (c conformation). One
of the ANT subunits is made of 293 amino acids
(AS). Three sections of intramembranous K-helices,
each of about 100 amino acids, which are combined
by loops outside the membrane, build up the tertiary
structure of a subunit. The amino acid sequences of
these sections are highly homologous to each other.
This tertiary structure is common for the ANT pro-
teins in several species. Thus, it is assumed that the
current ANT isoform genes descend from a common
primordial gene, which originally coded one of the
transmembrane structures [3]. The current gene
structure was subsequently developed by the process
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of gene duplications. The present isoforms were then
derived from this forerunner gene.
Two di¡erent isoforms (ANT1 and ANT2) were
identi¢ed in the rat [4]. The homology of their amino
acid sequences was shown to be 98%. Moreover, by
comparing the sequences of the rat-speci¢c ANT iso-
forms to the respective isoforms in man [3,5], cattle
[3] and mouse [6], high similarities of 94^98% were
found among the various species. This important
protein complex appeared to be highly sustained in
mammals. In order to improve our understanding for
the ANT isoform transcription we determined the
exact distribution of the isoform transcripts in vari-
ous tissues of the rat and in addition measured the
ANT transcription level using the quantitative PCR
technique.
2. Methods
2.1. Animals
Heart, skeletal muscle, brain, kidney, lung, spleen
and liver were taken from eight, 5 month old, male
Wistar Kyoto rats. The animals were delivered by the
Scho«nwalde Company, Germany. Specimens were
immediately snap-frozen in liquid nitrogen after re-
moval and stored at 380‡C awaiting analysis.
2.2. Ampli¢cation of ANT isoform-speci¢c cDNA
Total RNA was extracted from each tissue using
the LiCl method [7] and 250 ng of it was reverse
transcribed into cDNA in a reaction mixture (RT)
with an end volume of 20 Wl containing 4 Wl 5U¢rst
strand bu¡er (Gibco, Karlsruhe, Germany), 40 U
RNase inhibitor (Boehringer, Mannheim, Germany),
2.5 nmol of each dNTP, 8 ng random primer, 10 WM
DTT and 200 U MMLV-Reverse transcriptase (Gib-
co). Ampli¢cation of ANT1- and ANT2-speci¢c
cDNA was carried out in a mixture of 50 mM
Tris-HCl, 50 mM KCl, 0.001% gelatine, 1.5 mM
MgCl2, 0.4 WM of each primer (Table 1), 0.25 units
of Taq polymerase (Cetus Perkin Elmer, Weiterstadt,
Germany) and 10 Wl of the RT mixture, containing
cDNA and dNTPs, in an end volume of 50 Wl. The
denaturation, annealing and extension conditions for
the ampli¢cation were 45 s at 94‡C, 45 s at the cor-
responding annealing temperature (Table 1) and 90 s
at 72‡C. Thirty-¢ve ampli¢cation cycles were per-
formed with a thermal cycler (Biozyme, Oldendorf,
Germany). Both isoform-speci¢c cDNAs were simul-
taneously ampli¢ed by PCR using a primer pair,
which was complementary to the homologous se-
quences in the coding regions of the ANT isoforms
(Table 1). The ampli¢cation resulted in a PCR prod-
uct (tANT), containing ANT1 and ANT2 sequences,
each of them 629 bp long, with identical end sequen-
ces but di¡erent ANT isoform-speci¢c intermediate
nucleotide sequences.
2.3. Determination of ANT isoform-speci¢c mRNA
proportions
The proportions of ANT1- and ANT2-speci¢c se-
quences in the tANT product were subsequently de-
Table 1
Primers used for the ampli¢cation of ANT-speci¢c sequences
Isoform Primer sequences cDNA region (bp) [4] Annealing
temperature
(‡C)
Length of the
PCR products
(bp)
ANT1
Forward primer GTA GGC AAG AGC AAA AGA G 21^39 60 79
Reverse primer GGA TCT GTG AAC CTG TGA A 999^981
ANT2
Forward primer AAC ATG ACA GAT GCC GCT G 52^70 55 922
Reverse primer GGG GAG AAC AAC TAG GAC ATA A 973^952
tANT
Forward primer CTG CTG CTG CAG GTC CAG CA ANT1: 175^194; ANT2: 154^173 57 629
Reverse primer CCA GAC TGC ATC ATC AT ANT1: 803^787; ANT2: 782^766
bp, base pair.
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termined by a special dot blot hybridization proce-
dure as previously described in detail by Do«rner et
al. [8]. This method was adapted to the rat-speci¢c
nucleotide sequences. In brief, aliquots of the tANT
PCR product were denatured and dropped onto two
nylon membranes (Amersham, Germany). Addition-
ally, an ANT1- and ANT2-speci¢c cDNA standard,
respectively, was dropped in a dilution of 5^30 fmol
onto one of these membranes. The membranes were
hybridized with corresponding 32P-radioactively la-
beled ANT isoform-speci¢c oligonucleotides
(ANT1: 5P-GAT CGT CAT AAG CAG TTC-3P
and ANT2: 5P-GCT GGA GCT GAA AGG
GAA-3P). The hybridization and washing conditions
of the blots as well as the evaluation of the hybrid-
ization were the same as already published.
2.3.1. Preparation of ANT isoform standards
ANT1- and ANT2-speci¢c standard cDNA for the
dot blot procedure were produced as described by
Do«rner et al. [8], using rat-speci¢c primer pairs for
the ampli¢cation of the ANT isoform-speci¢c nu-
cleotide sequences (Table 1).
2.4. Southern blotting
Southern blot analyses were performed as previ-
ously published [8].
2.5. Determination of the amount of ANT-speci¢c
mRNA
The competitive q-PCR was employed for the de-
termination of the total ANT mRNA amount in the
various tissues of the rat. An internal mRNA stand-
ard (competitor) was used, which was simultaneously
reverse transcribed with the target RNA and com-
petitively ampli¢ed in the PCR.
2.5.1. Construction of the competitor
The competitor was produced using the PCR
MIMIC construction kit of Clontech (Heidelberg,
Germany). ANT-speci¢c primer sequences (tANT)
were linked to the delivered BamHI-EcoRI fragment
of erbB, an ANT non-homologous, neutral DNA
fragment of 574 bp, by means of the PCR technique.
PCR was carried out in a reaction mixture as de-
scribed above with 2 ng DNA fragment and 0.4
WM of each composite primer. Composite primers
consisted of ANT-speci¢c nucleotide sequences at-
tached to a nucleotide stretch of the sequence, de-
signed to hybridize on the heterogeneous DNA frag-
ment (forward primer: GCA GGT CCA GCA CAA
GTT TCG TGA GCT GAT TG; reverse primer:
GCA TCA TCA TTT GAG TCC ATG GGG
AGC TTT). The denaturation, annealing and exten-
sion conditions for the ampli¢cation were 45 s at
94‡C, 45 s at 60‡C and 90 s at 72‡C, respectively.
Sixteen ampli¢cation cycles were performed with a
thermal cycler (Biozyme). The ampli¢ed PCR prod-
uct was diluted 1/100 and 2 Wl was put into the sec-
ond PCR reaction. This PCR was made with the
primers used for the simultaneous ampli¢cation of
both isoforms (tANT) (Table 1) leading to a DNA
fragment with an ANT non-homologous internal se-
quence, 471 bp long and £anked by ANT-speci¢c
primer sequences.
This PCR product was inserted into the pCR2.0
vector and was multiplied in Escherichia coli INVKFP
according to the manufacturer’s instructions (Invitro-
gene, Leek, The Netherlands).
After plasmid preparation using a standard proto-
col, 5 Wg plasmid was digested with BamHI accord-
ing to the instructions of the manufacturer (Boehr-
inger). 1 Wg digested plasmid was transcribed into
cRNA using T7 polymerase (Gibco). The transcrip-
tion mixture was subjected to a 1% low-melting gel
electrophoresis. cRNA was extracted from the gel
using the QIAquick gel extraction kit (Qiagen, Hil-
den, Germany). In order to eliminate contaminating
DNA, cRNA was subjected to a DNA digestion. The
reaction was performed in a mixture containing 1 Wg
puri¢ed RNA, 1 Wl 10UDNAse I bu¡er, 1 U DNAse
I amp. grade (Gibco, Karlsruhe, Germany) ad 10 Wl
diethyl pyrocarbonate treated H2O for 15 min at
37‡C. The cRNA was puri¢ed by phenol/chloroform
extraction and quanti¢ed spectrophotometrically at
260 nm. The cRNA was stabilized with tRNA in a
concentration of 1 Wg tRNA to 1 ng RNA compet-
itor RNA. The purity of the competitor was proved
by PCR using non-transcribed cRNA as a template
and the tANT-speci¢c primer pair. No PCR product
was generated (data not shown).
2.5.2. Quantitative PCR
RNA of the di¡erent types of tissue was isolated
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as described by Au¡ray et al. [7]. The conditions of
the PCR were optimized, especially in view of the
cycles used and the amount of isolated total RNA
and standard cRNA. In the end the following con-
ditions were used. Equal amounts of total RNA (4
ng) were mixed with increasing amounts of compet-
itor (173, 86.5, 43.3, 21.6, 10.8, 5.4 or 2.7 attomol) in
a RT mixture of 20 Wl containing 4 Wl 5U¢rst strand
bu¡er (Gibco), 40 U RNase inhibitor (Boehringer),
2.5 nmol of each dNTP, 8 ng random primer, 10 WM
DTT and 200 U MMLV-Reverse transcriptase (Gib-
co). Competitive PCRs were carried out in a 25 Wl
reaction mixture containing 50 mM Tris-HCl, 50
mM KCl, 0.001% gelatine, 1.5 mM MgCl2, 2.5
nmol of each dNTPs, 0.4 WM of each tANT primer,
1 Wl RT mixture and 0.25 units of Taq polymerase
(Cetus Perkin Elmer). Conditions of ampli¢cations
were the same as mentioned above. Thirty-¢ve am-
pli¢cation cycles were performed with a thermal cy-
cler (Biometra, Go«ttingen, Germany). PCR products
were subjected to agarose gel electrophoresis and
stained with ethidium bromide. Gels were scanned
by a computer based video system (Polaroid, O¡en-
bach, Germany). The intensity of the ethidium bro-
mide stained bands of the target and the competitor
RNA was evaluated by a computer based image sys-
tem (NIH image). In order to correct for di¡erences
in size of the target (629 bp) and the competitor (471
bp) PCR products, the band densities of the respec-
tive competitor were multiplied by the speci¢c factor
of 1.33. The target/competitor ratio was plotted
against the amount of competitor in a log scale.
The linear regression was calculated. The amount
of competitor corresponding to a log ratio value of
0 is equivalent to the amount of total ANT-speci¢c
RNA in the specimens. The level of ANT transcrip-
tion was expressed as attomol/ng of total RNA.
3. Results
3.1. ANT isoform transcription patterns in various
tissues of the rat
PCR analyses were performed using ANT1- and
ANT2-speci¢c primer pairs and reverse transcribed
RNA isolated from various types of tissue of the
rat. Both ANT isoforms were shown to be tran-
scribed in all tissues tested (Fig. 1). PCR products
generated a clear sign of the predicted size on the
ethidium bromide strained agarose gel. PCR using
primers, which were complementary to homologous
sequences of both isoforms, led to an ampli¢cation
of total ANT (tANT) containing ANT1 and ANT2
cDNA with a length of 629 bp. The speci¢city of the
PCR reactions was subsequently tested performing
Southern blot hybridization. Isoform-speci¢c radio-
actively labeled oligonucleotides hybridized especially
with their corresponding type-speci¢c PCR product
as well as with the tANT product, consisting of
ANT1- and ANT2-speci¢c nucleotide sequences
(data not shown).
The exact percentages of ANT1- and ANT2-spe-
ci¢c cDNA contained in the tANT PCR product
were subsequently determined by a dot blot hybrid-
ization procedure. The binding of ANT1- and
ANT2-speci¢c radioactively labeled oligonucleotides
to the tANT product was compared to that of ANT
isoform-speci¢c DNA standards of known molarity,
Fig. 1. Transcriptions of the ANT1, ANT2 and total ANT
(tANT) were analyzed by qualitative PCR in the liver (a),
spleen (b), lung (c), kidney (d), brain (e), skeletal muscle (f) and
heart (g). PCRs were performed utilizing ANT1- and ANT2-
speci¢c primer pairs as well as a primer pair which recognized
homologous sequences in both ANT isoforms (Table 1). PCR
products were subjected to agarose gel electrophoresis. The
ANT1, ANT2 and tANT PCR products had predicted lengths
of 979 bp, 922 bp and 629 bp respectively.
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also applied to the dot blot. Using these standard
dilutions the content of each ANT isoform-speci¢c
cDNA in the tANT product was determined and the
percentages of ANT1 and ANT2 were calculated. A
predominant proportion of ANT1 transcription was
found in skeletal muscle, in heart tissue and in the
brain (Table 2). The lung, kidney and spleen had a
similar ANT isoform pattern characterized by a
dominant ANT2 proportion, ranging from 59 to
65%. The highest proportion of ANT2 was found
in the liver.
3.2. ANT transcription level in the various tissues of
the rat
Competitive PCR was employed in order to quan-
tify the original amount of total ANT (tANT)
mRNA in the various tissues of the rat. Quantitative
PCR was carried out using an internal RNA stand-
ard and the primer pair, leading to a simultaneous
ampli¢cation of all ANT isoform sequences (tANT)
(Fig. 2).
As illustrated in Fig. 3a, the level of total ANT
mRNA varied markedly in the various tissues of the
rat. The highest value of total ANT transcription
was found in the heart tissue, making up 40.9 þ 8.5
attomol/ng total RNA. The level of ANT transcrip-
tion was determined as being 28.0 þ 5.3 attomol/ng
total RNA in the brain and amounted to 23.9 þ 2.1
attomol/ng total RNA in skeletal muscle. The ANT
mRNA amount was substantially lower in the kid-
ney, making up 4.6 þ 1.0 attomol/ng total RNA.
However, even lower levels were found in the lung,
spleen and liver and were quanti¢ed to be an average
of 2.4 attomol/ng total RNA.
In order to additionally determine the precise
amount of ANT1- and ANT2-speci¢c mRNA in
the various types of tissue, the values of total ANT
mRNA amount, quanti¢ed by q-PCR, were com-
bined with the percentages of the ANT isoforms,
obtained from the dot blot hybridization procedure.
The highest ANT1 transcription level amounting to
24.9 þ 5.7 attomol/ng total RNA was found in the
heart, followed by that determined in skeletal muscle
(19.6 þ 1.8 attomol/ng total RNA) (Fig. 3b). The
ANT1 mRNA amount in the brain was also signi¢-
cantly higher (16.2 þ 3.0 attomol/ng total RNA) than
in tissues which have an ANT isoform transcription
pattern with a predominant ANT2 proportion. The
amount of ANT1 mRNA made up 1.6 þ 0.3 attomol/
ng total RNA and 1.1 þ 0.6 attomol/ng total RNA in
Table 2
Percentages of the ANT isoform mRNAs in various tissues of
the rat
Tissue ANT1 (%) ANT2 (%)
Skeletal muscle 81 þ 4 19 þ 4
Heart 63 þ 4 37 þ 4
Brain 58 þ 3 42 þ 3
Lung 41 þ 6 59 þ 6
Kidney 35 þ 6 65 þ 6
Spleen 36 þ 7 64 þ 7
Liver 25 þ 9 75 þ 9
Fig. 2. Total ANT mRNA quanti¢cation by competitive PCR.
A constant amount of total RNA (4 ng) isolated from kidney
was mixed with an increasing amount of competitor cRNA, re-
verse transcribed and ampli¢ed by PCR. (A) The PCR products
were subjected to agarose gel electrophoresis, stained and
scanned. The PCR products of the ANT target and the compet-
itor had expected lengths of 629 bp and 471 bp, respectively.
The band intensities were evaluated using a computer based im-
age system. (B) The ratio of target/competitor products was
plotted against the known amount of competitor on a log scale.
At the competition equivalence point (log ratio = 0) the original
content of the target mRNA corresponds to the initial amount
of competitor RNA used.
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the kidney and the lung, respectively. In the spleen
the ANT1 mRNA amount was found to make up
0.9 þ 0.3 attomol/ng total RNA. However, the lowest
ANT1 transcription level was measured in the liver
amounting to only 2% of that determined in the
heart (0.5 þ 0.4 attomol/ng total RNA).
A maximum ANT2 transcription level was also
recorded in the heart (16.0 þ 1.7 attomol/ng total
RNA), followed by that of the brain (11.8 þ 2.5 atto-
mol/ng total RNA) (Fig. 3c). The value of ANT2
mRNA amount was calculated to be 4.3 þ 1.0 atto-
mol/ng total RNA in the skeletal muscle. The ANT2-
speci¢c mRNA amounted to 3.0 þ 0.8 attomol/ng to-
tal RNA in the kidney and was even lower in the
lung, spleen and liver, making up 1.7 attomol/ng to-
tal RNA on an average.
4. Discussion
Two di¡erent ANT isoforms were identi¢ed in the
rat, which were shown to be di¡erently expressed in
various tissues [4,9]. However, the signi¢cance of tis-
sue-speci¢c ANT isoform expression has not been
totally understood. In order to ¢nd new aspects
which improve our knowledge of the ANT isoform
expression, we determined in this study the exact
percentages of the ANT isoform mRNAs and in ad-
dition quanti¢ed the level of the isoform transcrip-
tion in various organs of the rat. The Northern blot
technique was previously employed to describe the
transcription of the ANT isoform genes. This techni-
que, however, allows only for a rough appraisal of
the transcription levels. We therefore developed a
competitive PCR for the accurate quanti¢cation of
the ANT transcription. For this purpose, we used an
internal RNA standard and primers, which enabled
simultaneous ampli¢cation of both ANT sequences
in the mRNA original distribution. These primers
had already been utilized for the ampli¢cation of
6
Fig. 3. The content of total ANT (tANT) (a), ANT1 (b) and
ANT2 (c) mRNA in various types of tissue in the rat. The level
of total ANT transcription was determined by the use of the
competitive PCR technique as described in Fig. 2. The ANT1-
and ANT2-speci¢c mRNA amounts were calculated by combin-
ing the data obtained from the q-PCR with those from the dot
blot hybridization procedure.
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the three human ANT isoforms and can also be em-
ployed for the simultaneous multiplication of ANT
isoform sequences from cattle [3] and mouse [6]. We
subsequently determined the percentages of each
ANT isoform sequences in the PCR product of total
ANT by means of a dot blot hybridization proce-
dure. The combination of the q-PCR with the dot
blot hybridization procedure allowed additionally the
quanti¢cation of the ANT1 and ANT2 transcription
levels. The described technique is especially recom-
mendable if only small tissue samples are available.
The employed method provides an exact picture of
the ANT isoform transcription level and pattern in
the various types of tissues from the rat.
A predominant proportion of the ANT1 isoform
was found in the skeletal muscle, heart and brain,
ranging from 81 to 58% of total ANT transcription.
However, tissues such as lung, kidney, spleen and
liver showed a prevalent percentage of ANT2 tran-
scription. In contrast to the rat, the human organism
expresses three di¡erent ANT isoforms. Nevertheless,
ANT3 was not found to be prominent in any of the
tissues tested [8]. Thus, ANT3 seems to be of sub-
ordinate signi¢cance, particularly since it is missing
in several species including the rat [6]. ANT3 aside,
the distribution of the ANT1 and ANT2 isoforms in
the rat tissue is very similar to that found in man.
Highly conserved tissue-speci¢c ANT isoform tran-
scription programs obviously exist in mammals.
A common feature of the lung, kidney, spleen and
liver is, besides the predominant ANT2 mRNA per-
centage, the ability for cell regeneration, distinguish-
ing these tissues from the organs with a predominant
ANT1 transcription as shown in heart, skeletal
muscle and brain. In contrast to the ANT1 isoform,
ANT2 was shown to be a strongly growth-related
gene [10,11]. In connection with this, the in£uence
of thyroid hormones on the ANT expression was
intensively investigated [9,12,13]. Thyroid hormones
play a key role in the regulation of metabolism,
growth and development. ANT2 was shown to be
sensitive to T3, responding tissue-speci¢cally with
an increased transcription. In contrast, the ANT1
transcription was not positively a¡ected by T3.
Moreover, it has been found that thyroid hormones
in£uence the binding of regulatory proteins with a
negative-regulating element of the ANT1 gene [14],
thus possibly inhibiting the transcription in this way.
In addition, the developmental dependence of the
ANT gene regulation is impressively shown during
the development of myoblasts to already determined
muscle cells [15]. During the proliferation of the my-
oblasts a predominant ANT2 transcription was ob-
served, whereas it decreased when the cells entered
the di¡erentiation stage. At the beginning of this
phase a dramatic increase in the ANT1 mRNA
amount was found. Hence, ANT1 appeared to be
the isoform of tissues no longer subjected to prolif-
eration, whereas the ANT2 percentage is predomi-
nant in tissues able to divide mitotically.
The above does not eliminate a close correlation
between the oxygen consumption of the tissue, which
is a marker for the degree of oxidative phosphoryla-
tion and thus of ATP production, and the level of
total ANT expression. Since the ANT is the only
carrier for ATP in the mitochondrion, its amount
is adapted to the ATP production and to the amount
of mitochondria in the cell. Biochemical studies have
shown that the content of total ANT in the heart
mitochondria, making up 14% of the total mitochon-
drial protein, was markedly higher than the mito-
chondrial ANT amount in kidney or liver, amount-
ing to only 6% and 3% of the total mitochondrial
protein, respectively [16]. In this study, the ANT
mRNA amount in the heart tissue was found to be
approx. 9 and 17 times higher than that measured in
the kidney and liver, respectively. However, it is nec-
essary to take into consideration that not only the
ANT density in the mitochondria di¡ers in the var-
ious types of tissue but also the amount of mitochon-
dria itself. Since the amount of mitochondria in the
heart is substantially higher than in the kidney and
liver, the ANT transcription consequently has to be
markedly higher in the myocardium. The correlation
between the ANT transcription level and the degree
of oxidative phosphorylation is moreover shown by
the positive regulation of both isoform genes by oxy-
gen. Recent studies demonstrated that hypoxia
caused a decrease in the amount of ANT2 mRNA
in human hepatocellular carcinoma cells [17]. In ad-
dition, it was shown that the amount of ANT1 in
heart mitochondria decreased as a result of ischemia
[18]. Furthermore, investigations of the ANT isoform
regulation in yeast proved that the isoforms are dif-
ferently regulated by oxygen. It was shown that
ACC1 and ACC2 are positively regulated by the oxy-
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gen tension, whereas ACC3 is subjected to a negative
control of O2 [19^21]. Thus, both the levels of ANT1
and ANT2 expression are adapted to the energy de-
mand of the cell. This is con¢rmed by our ¢ndings
showing that there is not only a high level of ANT1
but also of ANT2 transcription in the heart and
muscle tissue.
The correlation between ATP production and
ANT expression level in the tissues ¢ts exactly,
with the exception of brain tissue. Comparing the
oxygen consumption of the various tissues, the en-
ergy requirement of the brain is lower than that of
the kidney. Therefore, the energy metabolic condi-
tions in the brain would lead us to expect a lower
level of ANT transcription than in the kidney.
Nevertheless, the level of total ANT transcription
in the brain is about 6 times higher than that in
the kidney. The observation made concerning the
ANT transcription of the brain, an organ with a
prevalent ANT1 proportion, led us to the conclusion
that (1) the main factor which determines the pre-
dominance of the ANT isoform expression in the
various tissues is not the energy requirement of the
tissue but the ability or inability to proliferate. (2) A
predominant ANT1 expression is accompanied by a
high level of total ANT transcription.
In summary, ANT isoform transcription is sub-
jected to a regulatory program in which developmen-
tal and energy-requiremental aspects are involved.
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